Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disorders
AssigneeSchering Corporation
InventorsThavalakulamgara K. Sasikumar, Wen-Lian Wu, Duane A. Burnett, Li Qiang
Life of this patent
Estimating the term…
Abstract
The present invention discloses compounds which are novel antagonists for melanin-concentrating hormone (MCH), as well as methods for preparing such compounds. In other aspects, the invention is directed to pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes. Compounds of the invention generally have the structure: 1 where the substituents are as defined herein.
Claims60
A compound represented by the structural formula:
- 80
- or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein
- X is —CH2—, —S(O2)—, carbonyl, —CHCH3 or —C(CH3)2—;
- Y is —(CR2R3)P—, —(CR2R3)PC(O)NH—, —(CR2R3)PNH—, —C(O)NH—, —C(O)(CR2R3)PNH—, —C(O)C(O)NH— or —C(O)(CR2R3)P—;
- Z is aryl, heteroaryl, R6-substituted aryl or R6-substituted heteroaryl;
- n is 0, 2 or 3, and when n is 0, no connecting bond exists between the two carbons adjacent to the nitrogen;
- p is 1, 2 or 3;
- q is 1, 2, 3, 4, 5 or 6;
- r is 0 or 1 and when r is 0, X is directly linked to the aromatic ring;
- R1 is hydrogen, -acyl, -alkyl, -cycloalkyl, -alkyl substituted with cycloalkyl, aralkyl, heteroaralkyl, —C(O)R5, —C(O)OR5, —C(O)OR8, —C(O)NR8R9, —S(O2)R5, —S(O2) NR8R9, cycloalkylalkyl, cycloalkylalkyl substituted with R10 on the -cycloalkyl ring, heterocyclyl, aryl, heteroaryl or —CF3;
- R2 and R3 can be the same or different, each being independently hydrogen, alkoxy or alkyl;
- or R2 and R3 can be joined together and with the carbon to which they are attached to form a 3 to 7 membered ring;
- R4 is aryl, heteroaryl, R7-substituted aryl or R7 substituted heteroaryl or Y—R4 taken together is
- 81
- R5 is alkyl, aryl, aralkyl, heteroaryl, cycloalkyl or heteroaralkyl;
- R6 is 1 to 5 substituents, each R6 can be the same or different and each is independently selected from —OH, -alkoxy, —OCF3, —CN, -alkyl, halogen, —NR8R9, —CONR8R9, —NR8S(O2)R6, —S(O2)NR8R9, —S(O2)R5, —COR5, —C(O)OR8, —CF3, —CHO, —C═NOR8,
- 82
- —(CR8R8)qNC(O)R11, —(CR8R8)qNS(O2)R12 and —(CR8R8)qNR8R9 wherein the R8 groups are independently selected;
- R7 is 1 to 5 substituents, each R7 can be the same or different and each is independently selected from hydrogen, —OH, -alkoxy, —OCF3, —CN, -alkyl, halogen, —NR8R9, —CONR8R9, —NR8S(O2)R6, —S(O2)NR8R9, —S(O2)R5, —COR5, —C(O)OR8, —CF3, -alkyleneNR8R9, —CHO, —C═NOR8 and —NR8C(O)R5, or two adjacent R7 groups can be joined together with two O atoms to form a methylene dioxy or ethylene dioxy group, —(CR8R8)qNR8R9, —(CR8R8)qNC(O)R11 and —(CR8R8)qNS(O2)R12, wherein the R8 groups are independently selected;
- R8 is hydrogen or -alkyl;
- R9 is hydrogen, -alkyl, -aryl or -heteroaryl;
- R10 is —OH, -alkoxy, —C(O)NR8R9, —NR8R9, —NR8S(O2)R5, —NR8C(O)NR8R9, —NR8C(O)R5, —NR8C(O)OR5, —C(O)OH or —C(O)OR5;
- R11 is alkyl, aryl, alkoxy or —NR8R9;
- and
- R12 is alkyl, aryl or —NR8R9.
A compound selected from the group consisting of:
- 90 91 92 93
Dependencies are inferred from the claim text.